Showing results (201-210 of 574) with videos related to

Sort By:
Pageof 58
Blood|March 1, 1981
Initial experience with AMSA as single agent treatment against malignant lymphoproliferative disordersF Cabanillas, S S Legha, G P Bodey, et al.
Archives of Pathology & Laboratory Medicine|September 1, 1981
Disseminated candidiasis caused by four different Candida speciesR L Hopfer, V Fainstein, M P Luna, et al.
The American Journal of Medicine|July 25, 1988
Cefoperazone plus mezlocillin for empiric therapy of febrile cancer patientsP Jones, G P Bodey, K Rolston, et al.
Biomaterials|June 1, 1996
In vitro antimicrobial efficacy of silver iontophoretic catheterI Raad, R Hachem, A Zermeno, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1988
Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion testsC C Sanders, J P Iaconis, G P Bodey, et al.
Oral Surgery, Oral Medicine, and Oral Pathology|May 1, 1985
Orofacial aspergillosis in acute leukemiaS Dreizen, G P Bodey, K B McCredie, et al.
Chemotherapy|January 1, 1987
In vitro evaluation of difloxacin (A-56619), A-56620, and other 4-quinolones against isolates from cancer patientsK V Rolston, D H Ho, B LeBlanc, et al.
Cancer|October 1, 1976
Fungemia due to Torulopsis glabrata in the compromised hostM Valdivieso, M Luna, G P Bodey, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1994
In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agentsN Khardori, H Nguyen, B Rosenbaum, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1987
In vitro evaluation of S-25930 and S-25932, two new quinolones, against aerobic gram-negative isolates from cancer patientsK V Rolston, D H Ho, B LeBlanc, et al.
Pageof 58